TCL Archive Translation Of “New Biology” Into Clinical Use Identified By DeVita As NCI’s Major Challenge August 16, 1985
TCL Archive Deals and Collaborations: Firms Get First Payment From Bristol-Myers for Taxol March 5, 1999
TCL Archive Former NCI, FDA Chief Andrew Von Eschenbach Appointed to NCCN Foundation Board June 17, 2011
TCL Archive News Analysis by Keith Baggerly: Duke Trials Went On Despite FDA Statements January 27, 2012
TCL Archive Accelerated Approval In Oncology Shaves A Year Off Development Time, FDA Data Show October 30, 2009
